)
Cryo Cell International (CCEL) investor relations material
Cryo Cell International Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for Oct. 27, 2026; record date Sept. 21, 2026, with 8,062,650 common shares outstanding and one vote per share.
Stockholders will elect four directors, ratify Wipfli LLP for FY2026, and vote on an advisory resolution approving named executive officer compensation.
Voting matters and shareholder proposals
Board unanimously recommends FOR all four director nominees, Wipfli's appointment, and the non-binding say-on-pay resolution.
Directors are elected by plurality; Proposals 2 and 3 require a majority of votes cast for or against. Abstentions and broker non-votes have no effect on Proposals 1–3.
Proxies may be submitted by mail, internet, or phone; electronic and phone votes must be received by 7 p.m. ET on Oct. 26, 2026. Proxies are revocable before voting.
Stockholder business for the 2027 annual meeting must generally be noticed July 15–Aug. 14, 2027; Rule 14a-8 proposals are due June 15, 2027, and universal proxy notice by Aug. 28, 2027.
Board of directors and corporate governance
Four nominees are current directors: David Portnoy, Mark Portnoy, Harold Berger, and Daniel Mizrahi; each would serve until the next annual meeting and successor qualification.
Board held nine meetings in FY2025; each director then in office attended at least 75% of applicable board and committee meetings. Berger and Mizrahi are independent directors.
David Portnoy is Chairman and Co-CEO with his brother Mark as Co-CEO; the Board has no lead independent director and cites decisive leadership and shared strategic decision-making as reasons for this structure.
Audit and Governance/Nominating Committees include Berger and Mizrahi; the Compensation Committee is chaired by Mizrahi and includes Berger. Each committee is composed of non-employee independent directors.
Director candidates are assessed for skills, experience, meeting availability, diversity, independence, and conflicts; stockholder-recommended candidates follow the same review process.
- Q3 earnings rose despite flat revenue; Duke litigation and listing compliance remain risks.CCEL
Q3 2026 - Revenue fell while Q2 net income rose, with expansion paused due to Duke arbitration and compliance risks.CCEL
Q2 2026 - Flat six-month revenue, lower net income, and Duke arbitration shape a cautious outlook.CCEL
Q2 2025 - Net loss of $2.4 million in 2025 driven by lower revenue and a $4.4 million inventory impairment.CCEL
Q4 2025 - Revenue and net income rose; Celle Corp. spinoff paused, dividend under review.CCEL
Q3 2024 - Revenue and net income increased, with ongoing R&D, facility expansion, and global growth focus.CCEL
Q2 2024 - Returned to profitability in 2024 with $32M revenue, after prior-year impairment losses.CCEL
Q4 2024 - Revenue up 2% to $7.97M, but net income fell and expansion paused due to Duke arbitration.CCEL
Q1 2025 - Revenue and net income fell as legal dispute with Duke University paused expansion plans.CCEL
Q3 2025
Next Cryo Cell International earnings date
Next Cryo Cell International earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)